147 related articles for article (PubMed ID: 19951285)
1. Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T.
Waters AM; Pappworth I; Marchbank K; Bockenhauer D; Tullus K; Pickering MC; Strain L; Sebire N; Shroff R; Marks SD; Goodship TH; Rees L
Am J Transplant; 2010 Jan; 10(1):168-72. PubMed ID: 19951285
[TBL] [Abstract][Full Text] [Related]
2. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.
Lee BH; Kwak SH; Shin JI; Lee SH; Choi HJ; Kang HG; Ha IS; Lee JS; Dragon-Durey MA; Choi Y; Cheong HI
Pediatr Res; 2009 Sep; 66(3):336-40. PubMed ID: 19531976
[TBL] [Abstract][Full Text] [Related]
3. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.
Hofer J; Janecke AR; Zimmerhackl LB; Riedl M; Rosales A; Giner T; Cortina G; Haindl CJ; Petzelberger B; Pawlik M; Jeller V; Vester U; Gadner B; van Husen M; Moritz ML; Würzner R; Jungraithmayr T;
Clin J Am Soc Nephrol; 2013 Mar; 8(3):407-15. PubMed ID: 23243267
[TBL] [Abstract][Full Text] [Related]
4. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.
Józsi M; Licht C; Strobel S; Zipfel SL; Richter H; Heinen S; Zipfel PF; Skerka C
Blood; 2008 Feb; 111(3):1512-4. PubMed ID: 18006700
[TBL] [Abstract][Full Text] [Related]
5. Atypical hemolytic uremic syndrome due to factor H autoantibody.
Uslu-Gökceoğlu A; Doğan CS; Comak E; Koyun M; Akman S
Turk J Pediatr; 2013; 55(1):86-9. PubMed ID: 23692839
[TBL] [Abstract][Full Text] [Related]
6. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
Abarrategui-Garrido C; Martínez-Barricarte R; López-Trascasa M; de Córdoba SR; Sánchez-Corral P
Blood; 2009 Nov; 114(19):4261-71. PubMed ID: 19745068
[TBL] [Abstract][Full Text] [Related]
7. Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS.
Grenda R; Jarmużek W; Rubik J; Prokurat S; Miklaszewska M; Drozdz D; Zachwieja K; Ardissino G; Hofer J
Pediatr Transplant; 2015 Sep; 19(6):E130-4. PubMed ID: 26087050
[TBL] [Abstract][Full Text] [Related]
8. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.
Moore I; Strain L; Pappworth I; Kavanagh D; Barlow PN; Herbert AP; Schmidt CQ; Staniforth SJ; Holmes LV; Ward R; Morgan L; Goodship TH; Marchbank KJ
Blood; 2010 Jan; 115(2):379-87. PubMed ID: 19861685
[TBL] [Abstract][Full Text] [Related]
9. Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein.
Krid S; Roumenina LT; Beury D; Charbit M; Boyer O; Frémeaux-Bacchi V; Niaudet P
Am J Transplant; 2012 Jul; 12(7):1938-44. PubMed ID: 22494769
[TBL] [Abstract][Full Text] [Related]
10. A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndrome.
Eyler SJ; Meyer NC; Zhang Y; Xiao X; Nester CM; Smith RJ
Pediatr Nephrol; 2013 Nov; 28(11):2221-5. PubMed ID: 23880784
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of DEAP-HUS with eculizumab.
Noone D; Waters A; Pluthero FG; Geary DF; Kirschfink M; Zipfel PF; Licht C
Pediatr Nephrol; 2014 May; 29(5):841-51. PubMed ID: 24249282
[TBL] [Abstract][Full Text] [Related]
12. Anti-Factor H autoantibodies in a fifth renal transplant recipient with atypical hemolytic and uremic syndrome.
Le Quintrec M; Zuber J; Noel LH; Thervet E; Frémeaux-Bacchi V; Niaudet P; Fridman WH; Legendre C; Dragon-Durey MA
Am J Transplant; 2009 May; 9(5):1223-9. PubMed ID: 19422347
[TBL] [Abstract][Full Text] [Related]
13. The clinical and laboratory features of Chinese Han anti-factor H autoantibody-associated hemolytic uremic syndrome.
Song D; Liu XR; Chen Z; Xiao HJ; Ding J; Sun SZ; Liu HY; Guo WY; Wang SX; Yu F; Zhao MH;
Pediatr Nephrol; 2017 May; 32(5):811-822. PubMed ID: 28035470
[TBL] [Abstract][Full Text] [Related]
14. Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome.
Strobel S; Hoyer PF; Mache CJ; Sulyok E; Liu WS; Richter H; Oppermann M; Zipfel PF; Józsi M
Nephrol Dial Transplant; 2010 Jan; 25(1):136-44. PubMed ID: 19666655
[TBL] [Abstract][Full Text] [Related]
15. The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.
Bhattacharjee A; Reuter S; Trojnár E; Kolodziejczyk R; Seeberger H; Hyvärinen S; Uzonyi B; Szilágyi Á; Prohászka Z; Goldman A; Józsi M; Jokiranta TS
J Biol Chem; 2015 Apr; 290(15):9500-10. PubMed ID: 25659429
[TBL] [Abstract][Full Text] [Related]
16. DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome.
Zipfel PF; Mache C; Müller D; Licht C; Wigger M; Skerka C;
Pediatr Nephrol; 2010 Oct; 25(10):2009-19. PubMed ID: 20157737
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of renal transplant in patients with anti-complement factor H antibody-associated hemolytic uremic syndrome.
Khandelwal P; Sinha A; Hari P; Bansal VK; Dinda AK; Bagga A
Pediatr Transplant; 2014 Aug; 18(5):E134-9. PubMed ID: 24814615
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies in haemolytic uraemic syndrome (HUS).
Skerka C; Józsi M; Zipfel PF; Dragon-Durey MA; Fremeaux-Bacchi V
Thromb Haemost; 2009 Feb; 101(2):227-32. PubMed ID: 19190803
[TBL] [Abstract][Full Text] [Related]
19. Successful discontinuation of eculizumab under immunosuppressive therapy in DEAP-HUS.
Hackl A; Ehren R; Kirschfink M; Zipfel PF; Beck BB; Weber LT; Habbig S
Pediatr Nephrol; 2017 Jun; 32(6):1081-1087. PubMed ID: 28220235
[TBL] [Abstract][Full Text] [Related]
20. Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children.
Sinha A; Gulati A; Saini S; Blanc C; Gupta A; Gurjar BS; Saini H; Kotresh ST; Ali U; Bhatia D; Ohri A; Kumar M; Agarwal I; Gulati S; Anand K; Vijayakumar M; Sinha R; Sethi S; Salmona M; George A; Bal V; Singh G; Dinda AK; Hari P; Rath S; Dragon-Durey MA; Bagga A;
Kidney Int; 2014 May; 85(5):1151-60. PubMed ID: 24088957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
